Detalhe da pesquisa
1.
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
Br J Cancer
; 130(6): 961-969, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38272963
2.
Extending the dosing intervals of nivolumab: model-based simulations in unselected cancer patients.
Br J Cancer
; 130(11): 1866-1874, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38532102
3.
Cardiac toxicity associated with pharmacokinetic drug-drug interaction between crizotinib and sofosbuvir/velpatasvir: A case report.
Br J Clin Pharmacol
; 89(4): 1486-1490, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36709977
4.
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 612-624, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35390339
5.
First referral to an integrated onco-palliative care program: a retrospective analysis of its timing.
BMC Palliat Care
; 19(1): 31, 2020 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32164672
6.
Timing of palliative care needs reporting and aggressiveness of care near the end of life in metastatic lung cancer: A national registry-based study.
Cancer
; 124(14): 3044-3051, 2018 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29742292
7.
Larotrectinib-Enhanced Radioactive Iodine Uptake in Advanced Thyroid Cancer.
N Engl J Med
; 383(17): 1686-1687, 2020 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33085869
8.
A PK/PD study of Delta-4 abiraterone metabolite in metastatic castration-resistant prostate cancer patients.
Pharmacol Res
; 136: 56-61, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30142421
9.
Erlotinib pharmacokinetics: a critical parameter influencing acute toxicity in elderly patients over 75 years-old.
Invest New Drugs
; 35(2): 242-246, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27796680
10.
Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients.
Invest New Drugs
; 35(4): 436-441, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28396974
11.
Quick, non-invasive and quantitative assessment of small fiber neuropathy in patients receiving chemotherapy.
J Neurooncol
; 127(2): 373-80, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26749101
12.
A Real-Life Experience of Bevacizumab in Elderly Women With Advanced Ovarian Carcinoma.
Int J Gynecol Cancer
; 26(7): 1196-200, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27643645
13.
Treatment of Advanced Renal-Cell Carcinoma.
N Engl J Med
; 374(9): 888, 2016 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26962912
14.
Adrenocortical carcinoma: Diagnosis, prognostic classification and treatment of localized and advanced disease.
Cancer Treat Res Commun
; 37: 100759, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37690343
15.
MAPK Pathway Inhibitors in Thyroid Cancer: Preclinical and Clinical Data.
Cancers (Basel)
; 15(3)2023 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765665
16.
Polyploid Giant Cancer Cells Are Frequently Found in the Urine of Prostate Cancer Patients.
Cancers (Basel)
; 15(13)2023 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37444476
17.
Pharmacokinetics/Pharmacodynamics of Dabrafenib and Trametinib for Redifferentiation and Treatment of Radioactive Iodine-Resistant Mutated Advanced Differentiated Thyroid Cancer.
Thyroid
; 33(11): 1327-1338, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725566
18.
Positive Correlation Between 18 F-FDG Uptake and Tumor-Proliferating Antigen Ki-67 Expression in Adrenocortical Carcinomas.
Clin Nucl Med
; 48(5): 381-386, 2023 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36758555
19.
Impact of sarcopenia indexes on survival and severe immune acute toxicity in metastatic non-small cell lung cancer patients treated with PD-1 immune checkpoint inhibitors.
Clin Nutr
; 42(6): 944-953, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099986
20.
Biweekly vs Triweekly Cabazitaxel in Older Patients With Metastatic Castration-Resistant Prostate Cancer: The CABASTY Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 9(12): 1629-1638, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37883073